I 
116TH CONGRESS 
2D SESSION 
H. R. 6600 
To authorize the Director of the National Institutes of Health to establish 
prize competitions to incentivize research by institutions of higher edu-
cation on point-of-care testing for the detection of current or past infec-
tion with COVID–19, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 23, 2020 
Mr. BEYER introduced the following bill; which was referred to the Committee 
on Energy and Commerce, and in addition to the Committee on Science, 
Space, and Technology, for a period to be subsequently determined by the 
Speaker, in each case for consideration of such provisions as fall within 
the jurisdiction of the committee concerned 
A BILL 
To authorize the Director of the National Institutes of 
Health to establish prize competitions to incentivize re-
search by institutions of higher education on point-of- 
care testing for the detection of current or past infection 
with COVID–19, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Point-of-Care Testing 
Prize Competitions Act of 2020’’. 
VerDate Sep 11 2014 
00:34 Apr 25, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6600.IH
H6600
pamtmann on DSKBC07HB2PROD with BILLS
SEC. 2. FINDINGS. 
Congress finds the following: 
(1) Prize competitions have been used through-
out America’s history, dating back to the designing 
of the United States Capitol Building in 1792. 
(2) The America COMPETES Reauthorization 
Act of 2010 granted authority for Federal agencies 
to carry out prize competitions in order to stimulate 
innovation to advance each agency’s mission. 
(3) Prize competitions provide a benefit to the 
American people by providing a high reward return 
on taxpayer dollars. 
(4) Since 2010, Federal agencies have con-
ducted nearly 1,000 prize competitions to help ad-
dress some of our Nation’s greatest challenges. 
(5) In order to mitigate the spread of COVID– 
19, Americans need access to rapid diagnostic test-
ing at the point of care. 
(6) Point-of-care infectious disease tests provide 
results in real time, rather than in hours or days. 
(7) Infectious disease tests are useful in re-
source-limited situations where there may not be ac-
cess to a central lab or where infrastructure is lim-
ited for transporting samples. Infectious disease 
tests at the point of care can also lead to prompter 
VerDate Sep 11 2014 
00:34 Apr 25, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6600.IH
H6600
pamtmann on DSKBC07HB2PROD with BILLS
treatment, which can prevent infections from spread-
ing. 
(8) Although other Federal agencies are cur-
rently involved in supporting and conducting re-
search into point-of-care testing, research spurred by 
prize competitions at the National Institutes of 
Health in consultation with the National Institute of 
Standards and Technology can have broader benefits 
for the American public. 
(9) The National Institute of Standards and 
Technology, due to its expertise in materials meas-
urement, including for DNA and other biological 
materials, is well positioned to support the National 
Institutes of Health in the development of reference 
materials and best practices for the assessment and 
validation of COVID–19 test results. 
SEC. 3. ESTABLISHMENT OF PRIZE COMPETITION. 
(a) IN GENERAL.—The Director of the National In-
stitutes of Health, in consultation with the Director of the 
National Institute of Standards and Technology, shall 
carry out prize competitions pursuant to section 24 of the 
Stevenson-Wydler Technology Innovation Act of 1980 (15 
U.S.C. 3719) to incentivize research by institutions of 
higher education on point-of-care testing for the detection 
of current or past infection with COVID–19. 
VerDate Sep 11 2014 
00:34 Apr 25, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H6600.IH
H6600
pamtmann on DSKBC07HB2PROD with BILLS
(b) REQUIREMENTS.—To be eligible for funding 
under this section, the point-of-care testing subject to the 
proposed research must be capable of— 
(1) producing results in 30 minutes or less; and 
(2) testing multiple samples simultaneously. 
(c) TIMING.—The Director of the National Institutes 
of Health shall— 
(1) publicize at least one prize competition pur-
suant to subsection (a) within 30 days after the date 
of enactment of this Act; and 
(2) publicize additional prize competitions pur-
suant to subsection (a) as determined appropriate by 
the Director. 
(d) NIST ASSISTANCE.—The Director of the Na-
tional Institute of Standards and Technology shall provide 
assistance to the Director of the National Institutes of 
Health on developing validation protocols and standards 
for testing developed pursuant to this section. 
Æ 
VerDate Sep 11 2014 
00:34 Apr 25, 2020
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H6600.IH
H6600
pamtmann on DSKBC07HB2PROD with BILLS